Hypertension in Young Patients: Approach and Management

Step 1: Confirm the Diagnosis

• Measure BP correctly: seated, after 5 minutes of rest, both arms
• Confirm with repeat readings on at least 2-3 separate visits
• Use ambulatory BP monitoring (ABPM) to rule out white-coat hypertension and masked hypertension
• Stage it: Stage 1 = SBP 130-139 or DBP 80-89; Stage 2 = SBP ≥140 or DBP ≥90

Step 2: Clinical Clues That Mandate a Secondary Workup

1. Severe or resistant/refractory hypertension
2. Acute rise in BP compared to a previously stable value
3. Proven onset before puberty
4. Non-obese patients under 30 years (this is a direct flag for secondary cause)
5. Hypertension with hypokalemia and metabolic alkalosis

Step 3: History and Physical Exam - Target Clues

Step 4: Initial Investigations (Baseline for All)

• Urinalysis + urine microalbumin - renal parenchymal disease
• Serum creatinine/eGFR + electrolytes - CKD, hypokalemia (aldosteronism)
• Fasting glucose + HbA1c - diabetes
• Lipid panel - cardiovascular risk
• Serum TSH - thyroid disease
• CBC - secondary causes
• ECG - LVH, arrhythmia
• Renal ultrasound - structural renal disease, PKD

Step 5: Targeted Secondary Workup Based on Clues

Step 6: Lifestyle Modifications (First-Line for All)

• Diet (DASH diet): High in fruits, vegetables, legumes, fish, low-fat dairy, nuts, whole grains; low in refined carbohydrates, sugar-sweetened beverages, saturated fat
• Sodium restriction: <1500 mg/day (most dietary sodium comes from processed foods)
• Physical activity: Aerobic or resistance exercise 90-150 min/week - reduces BP by 4-8 mmHg
• Weight reduction: Even modest weight loss significantly lowers BP
• Alcohol: ≤2 drinks/day in men, ≤1 drink/day in women
• Smoking cessation: Primarily for overall cardiovascular risk (not direct long-term BP effect)
• Stress management: Meditation, biofeedback, breathing exercises
• Goldman-Cecil Medicine, Treatment of Essential Hypertension

Step 7: Pharmacological Treatment

When to start medications:

• Stage 2 hypertension: Start alongside lifestyle changes
• Stage 1 + CVD or 10-year ASCVD risk ≥10%: Start medications
• Stage 1 without risk factors: Trial of lifestyle modification for 3-6 months first

First-line drug classes (all four are equally effective):

1. Thiazide-like diuretics (chlorthalidone preferred over HCTZ - longer acting)
2. Calcium Channel Blockers (CCB) - especially dihydropyridine (amlodipine)
3. ACE inhibitors (e.g., lisinopril, ramipril)
4. ARBs (e.g., losartan, telmisartan)

Combination therapy:

• Most patients with stage 2 hypertension need two drugs
• Preferred combination: Thiazide + ACE inhibitor/ARB OR CCB + ACE inhibitor/ARB
• Avoid combining ACE inhibitor + ARB together (harmful)
• Triple therapy: Thiazide + CCB + ACE inhibitor/ARB
• If triple therapy fails → add spironolactone, alpha-blocker, or beta-blocker → diagnose resistant hypertension

Special considerations in young patients:

• ACE inhibitors/ARBs: Preferred in young patients with diabetes, CKD, proteinuria, or heart failure; avoid in women of childbearing age without contraception (teratogenic)
• Beta-blockers: Good in patients with concurrent heart failure, post-MI, tachyarrhythmias; less favored as first-line for uncomplicated hypertension
• Oral contraceptive pill: Recognize as a drug cause; consider switching to progesterone-only or non-hormonal contraception
• FMD/renal artery stenosis: Percutaneous transluminal angioplasty is often curative in FMD; medical management with ACE inhibitors/ARBs works but must monitor renal function closely

Step 8: Treat the Underlying Cause if Secondary

• Primary aldosteronism: Adrenalectomy for adenoma; spironolactone for bilateral hyperplasia
• Pheochromocytoma: Surgical resection after alpha-blockade preparation
• Cushing's syndrome: Surgery (adrenalectomy or pituitary surgery)
• FMD/Renal artery stenosis: Angioplasty
• Hypothyroidism: Thyroid hormone replacement
• Sleep apnea: CPAP
• Drug-induced: Discontinue offending agent

Step 9: Target BP and Follow-Up

• Target BP: <130/80 mmHg for most young adults (ACC/AHA 2017 guideline)
• Monitor every 1-3 months until controlled, then every 3-6 months
• Screen for end-organ damage: LVH on ECG/echo, microalbuminuria, retinal changes, renal function
• Assess cardiovascular risk: treat dyslipidemia and diabetes concurrently
• A 5 mmHg reduction in SBP corresponds to ~10% reduction in cardiovascular events

Summary Algorithm

Young patient with elevated BP
        ↓
Confirm diagnosis (ABPM, repeat visits)
        ↓
Full history + physical exam (look for secondary clues)
        ↓
Baseline investigations (renal, electrolytes, glucose, TSH, urine)
        ↓
Targeted secondary workup if clues present
        ↓
Secondary cause found?
   YES → Treat cause + BP medications as needed
   NO  → Primary/Essential hypertension
        ↓
Lifestyle modification (all patients)
        ↓
Stage 1, low risk → Lifestyle trial 3-6 months
Stage 1 + risk / Stage 2 → Add medications
        ↓
First-line: Thiazide, CCB, ACE-i, or ARB
        ↓
Titrate, combine, aim for <130/80
        ↓
Resistant? → Rule out secondary, add spironolactone, refer specialist